Effect of N-acetylcysteine on cisplatin induced apoptosis in rat kidney
Bu makale için 30 Eylül 2025 tarihinde bir düzeltme yayımlandı. https://dergipark.org.tr/tr/pub/cumj/article/1790570
Öz
Purpose: Cisplatin is one of the most potent and widely used chemotherapeutic agents for the treatment of a wide variety of solid organ cancers. However, due to various side-effects such as nephrotoxicity, its therapeutic applications are limited. In the current study, it was aimed to investigate the effects of N-acetylcysteine (NAC), which is an effective antioxidant and anti-inflammatory agent, on cisplatin-induced apoptosis in rat kidneys.
Materials and Methods: Twentyfour male Wistar rats were separated into 4 equal groups: Control, NAC-250, cisplatin (CP), and CP+NAC groups. Rats in the experimental groups were treated with intraperitoneally (i.p.) single-dose cisplatin (10 mg/kg) and NAC (i.p., 250 mg/kg) for 3 days.
Results: At the end of the experiment, nephrotoxicity was confirmed by blood urea nitrogen and creatinine levels, and the apoptotic changes were demonstrated by TdT-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) and caspase-3 levels in rat kidneys. The number of TUNEL-positive cells and caspase-3 levels were significantly increased by cisplatin. Treating the rats with NAC significantly decreased TUNEL-positive cells and caspase-3 levels.
Conclusion: These data suggest that apoptotic cell death is involved in the pathogenesis of cisplatin-induced nephrotoxicity, and that the inhibition of apoptosis plays a central role in the beneficial effects of NAC.
Anahtar Kelimeler
Cisplatin, N-acetylcysteine, Apoptosis
Proje Numarası
TDK-2014-5056
Kaynakça
- 1. Dilruba S, Kalayda G. Platinum‑based drugs: past, present and future. Cancer Chemother Pharmacol. 2016; 77: 1103-1124.
- 2. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2010; 2 (11): 2490-2518.
- 3. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008; 73 (9): 994-1007.
- 4. Almanric K, Marceau N, Cantin A, Bertin É. Risk factors for nephrotoxicity associated with cisplatin. Can J Hosp Pharm. 2017; 70 (2) :99-106.
- 5. Nho JH, Jung HK, Lee MJ, Jang JH, Sim MO, Jeong DE, et al. Beneficial Effects of Cynaroside on Cisplatin-Induced Kidney Injury In Vitro and In Vivo. Toxicol Res. 2018; 34 (2): 133-141.
- 6. Lau AH. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int. 1999; 56 (4): 1295-1298.
- 7. Kaushal GP, Kaushal V, Herzog C, Yang C. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy. 2008; 4 (5): 710-712.
- 8. Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003; 1: 47-61.
- 9. Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018; 31 (1): 15-25.
- 10. Mi XJ, Hou JG, Wang Z, Han Y, Ren S, Hu JN, et al. The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK mediated pi3k/akt and p53 signaling pathways. Sci Rep. 2018; 29: 8 (1): 15922.
